Trials / Completed
CompletedNCT01383694
Effect Of Piperine In Patients With Oropharyngeal Dysphagia
Effect of Natural Agonists of TRPV1 in the Treatment of Functional Oropharyngeal Dysphagia in Neurological Diseases and the Elderly: Piperine
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Hospital de Mataró · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Piperine acts on the oropharyngeal TRPV1, increasing sensory input and the release of substance P. These actions may accelerate the oropharyngeal swallow response, improving the swallowing of dysphagic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Piperine |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2011-06-28
- Last updated
- 2015-03-03
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01383694. Inclusion in this directory is not an endorsement.